missing translation for 'onlineSavingsMsg'
Learn More

LILRA4 Rabbit anti-Human, Mouse, Polyclonal, Proteintech

Rabbit Polyclonal Antibody

Brand:  Proteintech 21153-1-AP-150UL

 View more versions of this product

Product Code. 16840765

  • 4652.90 SEK / 150µL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

ILT7 is a pDC-specific IgG-like transcript and is a member of the leukocyte immunoglobulin-like receptor gene family. This receptor, in complex with FcER1a, transduces ITAM-mediated signals which negatively modulate type I IFN production by pDC. ILT7 is thus a potential target to regulate Type 1 IFN production by pDC, which play a major role during viral infection, auto-immune diseases and anti-cancer immunity. Additionally, ILT7, along with CD123 and BDCA-2, can be used to identify or classify subsets of pDCalong with TLR expression and TLR mediated immune responses.
Specifications

Specifications

LILRA4
Polyclonal
Unconjugated
LILRA4
CD85g, ILT 7, ILT7, LILRA4
Rabbit
Antigen Affinity Chromatography
RUO
23547
-20°C
Liquid
Western Blot
0.41 mg/mL
PBS with 50% glycerol and 0.02% sodium azide; pH 7.3
P59901
LILRA4
LILRA4 Fusion Protein Ag15721
150 μL
Primary
Human, Mouse
Antibody
IgG
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title
LILRA4 Rabbit anti-Human, Mouse, Polyclonal, Proteintech > 150 μL; Unconjugated

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.